Presented the results of an Italian study on a nutraceutical that reduces cardiovascular risk by 27% by acting on the metabolic syndrome suffered by one in five Italians.

One in five Italians suffer from metabolic syndrome and therefore have a high risk of diseases such as diabetes, fatty liver (fatty liver) and cardiovascular diseases in general. Unregulated diet and little physical activity are the main culprits for the greater spread of this syndrome.

LAREPUBBLICA.IT